Dr. Daniel Acosta and In Vitro toxicology at the U.S. Food and Drug Administration's National Center for Toxicological Research.

Clicks: 342
ID: 62083
2019
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
For the past five years, Dr. Daniel Acosta has served as the Deputy Director of Research at the National Center for Toxicological Research (NCTR), a principle research laboratory of the U.S. Food and Drug Administration (FDA). Over his career at NCTR, Dr. Acosta has had a major impact on developing and promoting the use of in vitro assays in regulatory toxicity and product safety assessments. As Dr. Acosta nears his retirement we have dedicated this paper to his many accomplishments at the NCTR. Described within this paper are some of the in vitro studies that have been conducted under Dr. Acosta's leadership. These studies include toxicological assessments involving developmental effects, and the development and application of in vitro reproductive, heart, liver, neurological and airway cell and tissue models.
Reference Key
inselman2019drtoxicology Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Inselman, Amy;Liu, Fang;Wang, Cheng;Shi, Qiang;Pang, Li;Mattes, William;White, Matthew;Lyn-Cook, Beverly;Rosas-Hernandez, Hector;Cuevas, Elvis;Lantz, Susan;Imam, Syed;Ali, Syed;Petibone, Dayton M;Shemansky, Jennifer M;Xiong, Rui;Wang, Yiying;Tripathi, Priya;Cao, Xuefei;Heflich, Robert H;Slikker, William;
Journal toxicology in vitro : an international journal published in association with bibra
Year 2019
DOI
S0887-2333(18)30658-1
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.